Sino Biological,Inc. (301047.SZ)
| Previous Close | 69.17 |
| Open | 68.68 |
| Bid | 69.90 x N/A |
| Ask | 69.95 x N/A |
| Day's Range | 68.58 - 70.48 |
| 52 Week Range | 56.60 - 103.68 |
| Volume | |
| Avg. Volume | 556,176 |
| Market Cap | 9.03B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 34.77 |
| EPS (TTM) | 2.01 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.00 (2.86%) |
| Ex-Dividend Date | May 24, 2023 |
| 1y Target Est | 102.50 |
GlobeNewswireSino Biological Announces Services Partnership with Rapid Novor
Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services BEIJING, China, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce the formation of a services partnership with Toronto,
GlobeNewswireSino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
Sino Biological C4B Sino Biological Center for Bioprocessing HOUSTON, TX, Oct. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire — Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green,
